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Introduction
Ryanodine receptors (RyR) are intracellular Ca2+ channels
mainly found in excitable tissues, mediating Ca2+ release from
intracellular stores (Sutko and Airey, 1996; Franzini-Armstrong
and Protasi, 1997). The functional Ca2+ release channel is
composed of four ryanodine receptor monomers (each of which
has a molecular mass of approximately 560 kDa), which
assemble into a large macromolecular structure with a molecular
mass of more than 2106 Da (Bers, 2004; Serysheva et al., 2005;
Samso et al., 2005). Three isoforms of the RyR have been
identified at the molecular level: they share an overall amino acid
identity of approximately 60% and experimental evidence
suggests that they are structurally similar, with a large
hydrophilic NH2-terminal domain and a hydrophobic C-terminal
domain containing several transmembrane domains as well as
the channel pore (Bers, 2004; Serysheva et al., 2005; Samso et
al., 2005). Type 1 RyR (RyR1), encoded by a gene located on
human chromosome 19, is mainly expressed in skeletal muscle
where it mediates Ca2+ release from the sarcoplasmic reticulum,
following depolarization of the plasmalemma (Phillips et al.,
1996; Takeshima et al., 1989; Zorzato et al., 1990). Type 2 RyR,
encoded by a gene located on chromosome 1, is mainly
expressed in the heart and in certain areas of the cerebellum and
is activated through a Ca2+-induced Ca2+-release mechanism
(Otsu et al., 1990; McPherson and Campbell, 1993). Type 3
RyR, encoded by a gene located on chromosome 15, is
expressed in several tissues, including the central nervous
system; its expression in some tissues appears to be
developmentally regulated (Sorrentino et al., 1993; Tarroni et al.,
1997). In recent years, more detailed investigations have
revealed that this isoform-specific tissue distribution of RyR may
in fact be more complex. Sei et al. (Sei et al., 1999) and Hosoi
et al. (Hosoi et al., 2001) showed that circulating leukocytes, as
well as leukocyte-derived cell lines, express different RyR
transcripts. We have shown that Epstein Barr Virus (EBV)-
immortalized B-lymphocytes express the transcript, the protein
and the functional RyR1 Ca2+-release channel (Girard et al.,
2001), and O’Connell et al. (O’Connell et al., 2002) have
demonstrated that the RyR1 is expressed in immature mouse
dendritic cells (DCs). Immature DCs (iDCs) act as sentinels in
peripheral tissues, continuously sampling the antigenic
environment. Upon Toll-like receptor engagement by microbial
products or tissue debris, DCs undergo maturation and become
the most potent antigen-presenting cells. At this point, Toll-like
receptor-activated DCs upregulate costimulatory and antigen-
presenting molecules and migrate to secondary lymphoid organs
for the interaction with naive T-cells and the priming of immune
responses in vivo (Banchereau and Steinman, 1998). For several
years it has been known that increases in the intracellular
calcium concentration ([Ca2+]i) participate in the regulation and
maturation of DCs (Koski et al., 1999; Czerniecki et al., 1997),
although the mechanism and molecules involved in the early
steps of the Ca2+-release event have not been clearly defined.
As part of an investigation aimed at identifying the role of
RyR1 in cells of the immune system, we showed that in freshly
isolated human B-lymphocytes, activation of the RyR1 leads
Increases in intracellular Ca2+ concentration accompany
many physiological events, including maturation of
dendritic cells, professional antigen-presenting cells
characterized by their ability to migrate to secondary
lymphoid organs where they initiate primary immune
responses. The mechanism and molecules involved in the
early steps of Ca2+ release in dendritic cells have not yet
been defined. Here we show that the concomitant activation
of ryanodine receptor-induced Ca2+ release together with
the activation of Toll-like receptors by suboptimal
concentrations of microbial stimuli provide synergistic
signals, resulting in dendritic cell maturation and
stimulation of T cell functions. Furthermore, our results
show that the initial intracellular signaling cascade
activated by ryanodine receptors is different from that
induced by activation of Toll-like receptors. We propose
that under physiological conditions, especially when low
suboptimal amounts of Toll-like receptor ligands are
present, ryanodine receptor-mediated events cooperate in
bringing about dendritic cell maturation.
Key words: Dendritic cell, Maturation, Ryanodine receptor,
Signaling
Summary
Ca2+ signaling through ryanodine receptor 1 enhances
maturation and activation of human dendritic cells
Laura Bracci1,*,‡, Mirko Vukcevic2,*, Giulio Spagnoli1, Sylvie Ducreux2, Francesco Zorzato3 and
Susan Treves2,§
1Institute of Surgical Research and 2Departments of Anesthesia and Research, Basel University Hospital, Hebelstrasse 20, 4031 Basel,
Switzerland
3Department of Experimental and Diagnostic Medicine, General Pathology Section, University of Ferrara, 44100 Ferrara, Italy
*These authors contributed equally to this work
‡Present address: Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161, Rome, Italy
§Author for correspondence (e-mail: susan.treves@unibas.ch)
Accepted 5 May 2007
Journal of Cell Science 120, 2232-2240 Published by The Company of Biologists 2007
doi:10.1242/jcs.007203
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
2233RyR1 signaling in human dendritic cells
to the rapid release of the proinflammatory cytokine IL1B.
Furthermore, cells from patients with the malignant
hyperthermia susceptible phenotype, a pharmacogenetic
hypermetabolic disease caused by RYR1 mutations (Treves et
al., 2005), released more proinflammatory cytokines than cells
from controls, indicating that one of the downstream effects of
human RyR1 activation is coupled to cytokine release (Girard
et al., 2001). In the present study we investigated the effects of
pharmacological activation of RyR1 in human DCs. Our results
show that treatment of iDCs with RyR1 agonists is
accompanied by an increase in the intracellular calcium
concentration. Furthermore, treatment of iDCs with a
suboptimal concentration of bacterial lipopolysaccharide
(LPS) in the presence of RyR1 agonists induces activation of
cytokine transcription and upregulation of surface markers that
are typically associated with cell maturation as well as with an
increased capacity to stimulate allospecific T-cells. These
effects are specifically associated with RyR1 activation as they
could be blocked by pretreatment with the RyR1 antagonist
dantrolene (Zhao et al., 2001) and could not be induced by
addition of ATP, an agonist releasing calcium through IP3
mobilization (Ralevic and Burnstock, 1998; Schnurr et al.,
2004). These results provide for the first time evidence for the
involvement of RyR1 in DC maturation and indicate a
functional cooperation between RyR1-mediated and Toll-like
receptor-mediated intracellular signaling.
Results
Fig. 1A shows that peripheral blood monocytes cultured for 5
days in the presence of GM-CSF and IL4 differentiate into iDCs
(Sallusto and Lanzavecchia, 1994). These cells display a typical
immature phenotype in as much as they express the surface
markers CD1a, CD80, CD40, CD86 and CD54 and are negative
for CD83 (maturation marker) and CD14 (monocyte marker).
Furthermore, no positivity for CD3 (T-lymphocytes), CD19 (B-
lymphocyte marker) and CD56 (NK cell marker) could be
detected. Immature CD1a-positive DCs can be matured by
treatment with Toll-like receptor agonists, including bacterial
LPS (Sallusto et al., 1998). Fig. 1B shows that, irrespective of
their degree of maturation, DCs express the gene encoding the
skeletal muscle RyR1 but not the other isoforms. This transcript
is not expressed by other peripheral blood leukocyte populations
such as monocytes (which express the RyR2 isoform transcript)
and T-lymphocytes (Fig. 1B), but is expressed by plasmacytoid
DCs, which are natural circulating DCs isolated from peripheral
blood as opposed to cells obtained upon in vitro culture.
Immunofluorescence analysis shows that the intracellular
distribution of the RyR1 in in vitro-derived CD1a-positive DCs
is concentrated in a reticulum extending from the perinuclear
area towards the plasma membrane. Confocal analysis of 1 m
optical slices shows no surface fluorescence, confirming that the
RyR1 is expressed in intracellular membrane compartments,
most likely the endoplasmic reticulum (Fig. 1C).
Fig. 1. Expression of RyR in human DCs. Peripheral blood monocytes were induced to differentiate into iDCs by 5-day culture in IL4 and
GM-CSF. (A) Cells were then washed and incubated in the presence of fluorochrome-labeled monoclonal antibodies (mAbs) recognizing the
indicated surface markers. Specific fluorescence (full histograms) was evaluated by taking advantage of a FACSCalibur flow cytometer
equipped with Cell Quest software (Becton Dickinson) using, as negative controls, isotype-matched irrelevant reagents (empty histograms).
One representative experiment out of five is shown. (B) Total RNA was extracted from immature (iDCs), LPS-matured (mature DCs) and from
other cell types, and the expression of genes encoding the different RYR isoforms was evaluated by RT-PCR. RNA from EBV-transformed
lymphocytes was used as control for RYR1 isoform gene expression. (C) Immunofluorescence analysis of iDCs. Cells were stained with goat
anti-RyR polyclonal Ab followed by Alexa Fluor-555-conjugated anti-goat Ab (a-j), Alexa Fluor-555-conjugated anti-goat Ab alone (k) or with
allophycocyanine-conjugated anti-CD1a (l). Immunofluorescence analysis on acetone:methanol-fixed iDCs reveals strong perinuclear RyR
fluorescence that extends into the endoplasmic reticulum network. Panels a-j show 1 m optical slices from the bottom upwards; bar, 10 m.
Images were acquired with a 100 Plan Neofluar oil immersion objective (NA 1.3) mounted on a Zeiss Axiovert 100 confocal microscope.
Panel l: paraformaldehyde fixed DCs display typical plasma membrane fluorescence for the CD1a marker (bar, 20 m).
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Single-cell intracellular Ca2+ measurements on fura-2-
loaded iDCs show that addition of 10 mM caffeine leads to a
rapid and transient increase in the [Ca2+]i (Fig. 2A). Data
presented in Fig. 2B confirm that the RyR1 can also be
activated pharmacologically with specific agonists such as
caffeine and 4-chloro-m-cresol (Zucchi and Ronca-Testoni,
1997) as well as by KCl. The addition of 100 M ATP, which
induces Ca2+ release through InsP3 receptor activation in many
cell types (Ralevic and Burnstock, 1998; Schnurr et al., 2004),
was also accompanied by an increase in [Ca2+]i in iDCs (Fig.
2C). Interestingly, the peak amplitude induced by ATP was
significantly larger than that observed after RyR1 activation
(compare Fig. 2B and Fig. 2D; P<0.00001). These results
unequivocally demonstrate that increases in intracellular [Ca2+]
in human iDCs can be stimulated both by InsP3 mobilizing
agonists as well as by RyR1 activators. We next investigated
whether the Ca2+ released through RyR1 activation plays a
specific function in DC maturation.
Immature DCs generated by culturing peripheral blood
monocytes for 5 days in the presence of IL4 and GM-CSF were
induced to mature by 18 hours of incubation with increasing
concentrations of LPS (from 1 ng/ml to 1 g/ml) in the
Journal of Cell Science 120 (13)
presence of 10 mM caffeine. The expression of genes
associated with DC maturation and their capacity for
stimulating T-cell responses was then evaluated. Fig. 3 shows
the results obtained in a typical experiment representative of
data obtained with four different donors. Low (sub-optimal)
concentrations (1 ng/ml) of LPS only slightly activated the
transcription of the genes under investigation, whereas the
addition of an optimal LPS concentration (1 g/ml) strongly
stimulated the transcription of genes encoding the maturation
marker CD83 and IFN, IL12B and IL23A, cytokines that are
associated with a high capacity of stimulating T-cell responses.
Importantly, costimulation of DCs for 18 hours with 10 mM
caffeine plus 1 ng/ml LPS stimulated transcription of all the
genes under investigation to extents similar to those obtained
using a 1000-fold higher concentration of LPS alone. The
involvement of RyR1 activation is supported by the fact that
pretreatment of cells with the RyR1 antagonist dantrolene
followed by the addition of caffeine and LPS inhibited the
synergistic effects of caffeine and LPS on gene expression (Fig.
3A). Quantitatively and qualitatively similar results were
obtained when iDCs were treated with 4-chloro-m-cresol and
LPS, but in some cases the presence of the latter RyR1 agonist
was accompanied by apoptosis, resulting in more variable
results (data not shown). Fig. 3B shows that in human DCs
Ca2+ release mediated by the activation of the InsP3-signaling
pathway induced by 100 M ATP in the presence of 1 ng/ml
LPS could only partially activate DCs, as detected by the
expression of the IL23A gene, albeit at a fourfold lower extent
than that observed upon RyR1 activation. By contrast, it was
not potent enough to induce transcription of the genes encoding
CD83, IL12B and IFN. The addition of 10 mM caffeine alone
(i.e. in the absence of LPS) caused an increase in IL23A gene
expression, but did not affect transcription of the other genes
under investigation (Fig. 3B, right panel).
Finally, increasing concentrations of caffeine (from 1-10
mM + 1 ng/ml LPS) resulted in a proportional increase of
IL23A gene transcription, reflecting the calcium-dependent
nature of this activation event (Fig. 3C); this result was further
confirmed by the observation that addition of 1 M
thapsigargin [an inhibitor of sarcoplasmic and endoplasmic
reticulum Ca2+-ATPases (SERCA)] in the presence of 1 ng/ml
LPS resulted in the activation of IL23A gene transcription (Fig.
3C).
We then examined in more detail the functional
consequences of the maturation signals generated by
simultaneous RyR1 and Toll-like receptor activation. The
capacity of iDCs treated with LPS plus caffeine to stimulate
allospecific T-cell proliferation was assayed by measuring
[3H]thymidine incorporation. As shown in Fig. 3D, iDCs are
relatively poor allostimulatory cells (white bars) and the low
dose of LPS used to activate DCs in this assay (1 ng/ml) was
also not so efficient, causing a 1.6-fold increase in T-cell
proliferation (grey bars). Incubation of iDCs with 100 M ATP
(which induces a large [Ca2+]i transient) plus 1 ng/ml LPS did
not significantly improve [3H]thymidine incorporation by T
cells (horizontally lined bars), as compared with LPS treatment
alone. However, treatment of iDCs with 10 mM caffeine plus
1 ng/ml LPS provided synergistic signals resulting in a twofold
increase in [3H]thymidine incorporation in T cells (hatched
bars). This effect was specific as it could be blocked by
inhibiting RyR1-mediated Ca2+ signaling by pretreating iDCs
Fig. 2. Single-cell intracellular calcium imaging on iDCs.
(A,C) Single-cell intracellular calcium measurements in fura-2-
loaded iDCs obtained after 5 days of culture. The traces show
changes in fura-2 fluorescence ratio (340/380 nm) in a single iDC
after addition of caffeine or ATP. Experiments were performed in
Krebs-Ringer containing 1 mM Ca2+. (B,D) Average peak increases
in fluorescence ratio induced by the addition of the indicated
agonists to fura-2-loaded iDCs. Results represent the mean 
increase in fluorescence (calculated by subtracting the peak
fluorescent ratio from the resting fluorescent ratio) obtained after
addition of 600 M 4-chloro-m-cresol, 10 mM caffeine or 150 mM
KCl (B) or 100 M ATP (D). No difference was found in the peak
Ca2+ in response to RyR activation (P=0.820), but the amount of
Ca2+ released by 100 M ATP was significantly higher (P<0.00001).
Results represent the mean (± s.e.m.)  increase in fluorescence in
DCs isolated from four different donors.
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with 20 M dantrolene, prior to the addition of 10 mM caffeine
and 1 ng/ml LPS (diagonally lined bars). Taken together, these
results suggest that the signals generated in human DCs
through Toll-like receptors (by the addition of LPS) and by
RyR1 activation are different, and that their combined
activation results in synergistic effects.
Although RyR1 can be pharmacologically activated by a
variety of agonists, how its activation occurs in iDCs in vivo
remains puzzling. We were intrigued by the finding that the
addition of KCl causes a rise in the [Ca2+]i in iDCs and
reasoned that this may have physiological relevance. In fact,
cells dying in the vicinity of iDCs in a restricted
microenvironment such as an inflamed tissue could release
their intracellular K+ into the extracellular milieu, thereby
providing the necessary costimulating signal(s) to iDCs
residing in neighboring areas. In order to verify our hypothesis,
we set up a series of experiments; first we tested whether the
effects of caffeine on DC maturation could be monitored by
flow cytometry, by following the surface expression of CD83,
a good phenotypic indicator of DC maturation (Zhou and
Tedder, 1996; Lachmann et al., 2002). Fig. 4A shows that as
early as 4 hours after stimulation 1 g/ml LPS induced
significant surface expression of CD83; this incubation time
was chosen for all subsequent experiments and the results
obtained by adding different stimuli were compared with those
obtained by treating cells with 1 g/ml LPS, which was set at
100% induction of CD83 expression. Fig. 4A shows that
addition of 10 mM caffeine alone, 100 M ATP plus 1 ng/ml
LPS, or pretreatment of cells with 20 M dantrolene followed
by the addition of 10 mM caffeine plus 1 ng/ml LPS did not
result in significant induction of CD83 expression.
Pretreatment of DCs with 20 M dantrolene did not affect the
induction of CD83 surface expression stimulated by 1 g/ml
LPS. However, the addition of 10 mM caffeine plus 1 ng/ml
LPS caused a significant induction of CD83 surface expression
(P<0.001; Student’s t-test).
We followed the same protocol to verify whether the
hypothesis that KCl or the content of necrotic cells could
Fig. 3. RyR activation induces transcription of genes involved
in DC maturation and potentiates allospecific T-cell
stimulation. (A) In vitro-derived iDCs were cultured for 18
hours in the presence of the indicated concentrations of LPS
and with 10 mM caffeine and 20 M dantrolene, as indicated.
Total RNA was extracted and CD83, IFN, IL12B and IL23A
gene expression was evaluated by quantitative real-time PCR.
Gene expression results are expressed as fold-increase as
compared with values obtained in iDCs treated with medium +
1 ng/ml LPS. One representative experiment out of four is
shown. (B) Experiment as in A except that in vitro-derived
iDCs were cultured for 18 hours in the presence of 1 ng/ml
LPS + 100 M ATP (left panel) or in the presence of 10 mM
caffeine and 20 M dantrolene, as indicated (right panel).
Gene expression results are expressed as fold-increase as
compared with values obtained in iDCs treated with medium +
1 ng/ml LPS (left panel; ATP experiments) or as fold-increase
as compared with values obtained in iDCs treated with
medium alone (right panel). One representative experiment out
of four is shown. (C) Experiment as in A except that in vitro-
derived iDCs were cultured for 18 hours in the presence of 1
M thapsigargin, or the indicated concentration of caffeine or
1 M thapsigargin + 1 ng/ml LPS. Total RNA was extracted
and IL23A gene expression was evaluated by quantitative real-
time PCR. One representative experiment out of four is shown.
(D) Immature DCs were harvested on day 5 of differentiation
and stimulated with 1 ng/ml LPS (grey box), with 10 mM
caffeine + 1 ng/ml LPS (hatched box), with 20 M dantrolene
+ 10 mM caffeine + 1 ng/ml LPS (diagonal lines) or with 100
M ATP + 1 ng/ml LPS (horizontal lines), or left untreated
(empty box). DCs were then washed and added to allogenic
PBMC at a ratio of 10:1 for 5 days. [3H] thymidine was then
added and cells were cultured for another day. The bars
indicate the mean value of c.p.m. (± s.e.m.) from triplicate
samples from one donor. The experiment was repeated with
similar results at least four times with different donors.
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mimic the synergistic effects of caffeine on iDC maturation.
Immature DCs were incubated with Krebs-Ringer in which
NaCl was substituted for KCl (in order to maintain the
osmolarity), plus 1 ng/ml LPS for 30 minutes at 37°C; the
medium was then replaced by differentiation medium
containing 1 ng/ml LPS and the cells were incubated for 4
hours. The KCl-washout step was necessary as iDCs were
sensitive to prolonged exposure to KCl. As shown in Fig. 4B,
the addition of KCl and sub-optimal LPS (1 ng/ml) to iDCs
promoted surface expression of CD83, which could be
inhibited by pretreatment with 20 M dantrolene. Fig. 4C
shows that the addition of filtered soluble extracts from
necrotic HEK293 cells in the presence of 1 ng/ml LPS caused
a significant number of cells to express surface CD83; this
stimulation of CD83 surface expression was significantly
decreased by preincubation with 20 M dantrolene
(P<0.0001), or by dialysis of the filtered extracts (P<0.005). In
the former cases, however, some induction of CD83 expression
was still present, indicating that other factors promoting iDC
maturation independently of RyR activation are also released
from dying cells.
In order to dissect the intracellular pathways involved in
Toll-like receptor and RyR activation, we examined (1) the
effects of LPS and caffeine on the translocation of p65 (RelA,
a component of the NF-kB complex) to the nucleus and (2) the
Journal of Cell Science 120 (13)
sensitivity of DC maturation to cyclosporine A, which would
suggest the involvement of the Ca2+/calmodulin phosphatase,
calcineurin. Fig. 5A (top panels) shows that in untreated iDCs
and in cells treated for 5 minutes with 10 mM caffeine and/or
1 ng/ml LPS, p65 was mainly distributed in the cytoplasm;
however, incubation with 1 g/ml LPS for 60 minutes caused
its nuclear translocation in a large number of cells (Fig. 5A,
bottom panel, arrowheads). Caffeine stimulation of iDCs
evokes a low-amplitude calcium signal (Fig. 2), and this low-
amplitude calcium signal alone or in combination with 1 ng/ml
LPS is not sufficient to activate the nuclear translocation of NF-
kB. These results support the hypothesis that some intracellular
signals generated by LPS-mediated activation of Toll-like
receptors in DCs are led by NF-kB-dependent events, whereas
caffeine-activated pathways are NF-kB independent.
We next investigated whether the caffeine low-amplitude
calcium signal is sufficient to activate an alternative signaling
pathway, namely Ca2+/calmodulin-dependent phosphatase
calcineurin. We probed the effect of caffeine on maturation of
iDCs by using the calcineurin pathway inhibitors cyclosporine
A (Barford, 1996) and deltamethrin (Enan and Matsumara,
1992). Fig. 5B shows that the synergistic effects of 1 ng/ml
LPS and 10 mM caffeine (light-grey bars) on maturation of
iDCs could be completely abrogated by pretreatment of iDCs
with 2 M cyclosporine A and 10 M deltamethrin. These
Fig. 4. Incubation of iDCs with KCl or soluble extracts from necrotic cells promotes surface expression of CD83. iDCs were treated for 4 hours
as indicated and the percent positive CD83 cells was determined by flow cytometry. (A) Stimulation with 10 mM caffeine alone or 100 M
ATP + 1 ng/ml LPS did not significantly increase CD83 surface expression; incubation with 10 mM caffeine + 1 ng/ml LPS significantly
increased CD83 surface expression (P<0.001). This effect was blocked by pretreatment with 20 M dantrolene. (B) When KCl was added, cells
were incubated with Krebs-Ringer saline (in which the NaCl had been substituted for KCl) for 30 minutes at 37°C; they were then centrifuged,
and fresh medium containing 1 ng/ml LPS was added and cells were incubated at 37°C for 4 hours. (C) For experiments in which iDCs were
incubated with the supernatant from necrotic HEK293 cells, extracts were prepared as described in the Materials and methods section and
either used directly (+ necrotic cell extract ± 20 M dantrolene) or dialysed overnight against 1PBS (dialysed necrotic cell extract). Results
are expressed as mean (± s.e.m.) percentage induction of CD83 surface expression of at least three experiments performed on iDCs purified
from blood of different donors; values obtained by treating iDCs with 1 g/ml LPS was considered 100%. *P and **P, significant difference in
the treated population compared with iDCs treated with 1 ng/ml. ***P, significant difference from iDCs treated with 1 ng/ml LPS + necrotic
cell extracts.Jo
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results are consistent with the idea that in addition to NF-kB
the Ca2+-calcineurin-sensitive signaling pathway is also
involved in the maturation of human DCs.
Discussion
The present study shows that activation of RyR1 in iDCs
generates, through a calcineurin-sensitive pathway, a
costimulatory signal that enhances the sensitivity of iDCs to
bacterial stimuli, leading to their maturation. These effects are
unveiled when subthreshold concentrations of LPS are used.
DCs express both IP3R and RyR1 intracellular Ca2+ channels
(Hosoi et al., 2001; Stolk et al., 2006; Goth et al., 2006) and
the involvement of Ca2+-dependent signaling events in their
activation has been clearly established. In fact, (1) treatment of
human iDCs with the Ca2+ ionophore A23187 induces
upregulation of major histocompatibility complex (MHC) and
costimulatory molecules and CD83 expression (Czerniecki et
al., 1997) and activates the transcription of IL23A (this study),
and (2) promotes T-cell activation (Faries et al., 2001).
Moreover, (3) treatment of mature human DCs with ionomycin
triggers release of pro-IL-1 (Gardella et al., 2001).
As to the types of intracellular Ca2+-release channels
involved in DC activation and/or maturation, Stolk et al.
recently showed the RyRs are not indispensable because bone
marrow precursors obtained from the liver of RyR1 knockout
(KO) mice injected into sublethally irradiated congenic hosts
could still be induced to differentiate and mature into normal
DCs (Stolk et al., 2006). Notably, however, the Ca2+ signaling
machinery possesses a vast array of toolkit components, which
can be mixed and matched to deliver Ca2+ signals (Berridge et
al., 2003). Thus, one can assume that in the DC precursors
obtained from (lethal) RyR1 KO mice other molecules
involved in intracellular Ca2+ signaling are compensating for
the depletion of RyR1. Clearly, under physiological conditions
RyR1 activation, together with signals generated through
triggering of Toll-like receptors, generates costimulatory
signals involved in the maturation of human DCs.
An interesting observation arising from this study is that
addition of KCl to iDCs is accompanied by a rapid and transient
increase in [Ca2+]i. In skeletal muscle, depolarization of the
plasma membrane is sensed by an L-type Ca2+ channel, which
undergoes a conformational change allowing it to interact
directly with the RyR, thereby activating Ca2+ release from the
sarcoplasmic reticulum (Sutko and Airey, 1996; Franzini-
Armstrong and Protasi, 1997). Although DCs are not electrically
excitable, one can envisage that massive release of KCl from
cells dying in the vicinity of DCs may activate sensitive channels
present on the plasma membrane coupled to the RyR1, thereby
leading to RyR1 activation and thus Ca2+ release. Such a
conclusion is supported by two sets of data: (1) the
demonstration that treatment of iDCs with KCl promotes surface
expression of CD83, which can be antagonized by dantrolene,
and (2) the fact that incubation of iDCs with filtered soluble
extracts, but not dialysed extracts, from necrotic cells promoted
surface expression of CD83 that could partially be prevented by
the addition of dantrolene. Similar results were reported by
Sauter et al. (Sauter et al., 2000), who showed that incubation
of iDCs with extracts from necrotic cells, but not apoptotic cells,
induces DC maturation. Clearly, some of the signals generated
by necrotic cells are capable of activating the iDC RyR,
providing maturation stimuli. Based on these results, we propose
that the intracellular contents released from dying cells in the
vicinity of iDCs provide RyR1-dependent costimulatory
signal(s), leading to full maturation of DCs even in the presence
of suboptimal concentrations of bacterial stimuli. A schematic
representation of our hypothesis concerning the signals
Fig. 5. LPS but not caffeine induces nuclear translocation of NF-kB, whereas caffeine-induced maturation is sensitive to cyclosporine A (CsA).
iDCs were left untreated or stimulated for 5 or 60 minutes at 37°C, as indicated. Cells were allowed to stick to poly-L-lysine-treated coverslips
and permeabilized with acetone:methanol. Cells were incubated with rabbit anti-p65 polyclonal antibodies (Ab), followed by Alexa Fluor-488-
labeled secondary Ab and visualized with a confocal microscope as indicated in the Materials and Methods section. Arrowheads indicate
nuclear fluorescence. Images were acquired with a 100 Plan Neofluar oil immersion objective (NA 1.3) mounted on a Zeiss Axiovert 100
confocal microscope. Horizontal bar, 10 m. Arrowheads point to nuclear translocation of p65. (B) Surface expression of CD83 in
unstimulated iDCs (empty bars) or iDCs stimulated with 1 ng/ml LPS (dark-grey bars) ± 10 mM caffeine (light-grey bars) or pretreated with
2 M CsA for 30 minutes and then with 10 mM caffeine + 1 ng/ml LPS (slashed grey bars), or pretreated with 10 M deltamethrin for 30
minutes and then with 10 mM caffeine + 1 ng/ml LPS (hatched grey bars). Results are expressed as percent (mean ± s.e.m.; n=3) induction of
CD83 surface expression: 100% was the value obtained by stimulating cells with 1 g/ml LPS for 4 hours. **P, significant difference in the
treated population compared with iDCs treated with 1 ng/ml.
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underlying RyR1 activation and their involvement in the event
leading to iDC maturation is illustrated in Fig. 6.
As to the involvement of specific transcription factors in DC
maturation and function, NF-kB has been shown to play a role
in the regulation of transcription of several genes, including
those encoding IL1A and IL1B, IL6, IL8, IL12B, TNF and
IFN and CD86 (Ghosh et al., 1998; Grohmann et al., 1998;
Lee et al., 1999). Under resting conditions NF-kB forms an
inactive complex (NF-kB1+RelA+IkB) detectable in the
cytoplasm, which upon activation translocates to the nucleus
where it binds to specific promoter sequences and functions as
a transcriptional activator. Although it is well-established that
the activation of Toll-like receptors by LPS induces nuclear
translocation of NF-kB (Ghosh et al., 1998; Lee et al., 1999)
(and this study), this does not occur with caffeine, suggesting
the involvement of other (Ca2+-dependent) transcriptional
regulators. In a previous study we showed that RyR1 activation
in human myotubes leads to cyclosporine-A-sensitive IL6
release (Ducreux et al., 2004). In DCs, the effects of
cyclosporine A are controversial: one report suggests that
pretreatment with cyclosporine A increases maturation and
CD80 expression (Ciesek et al., 2005), whereas others report
that cyclosporine A inhibits IL12 production and upregulation
of costimulatory molecules induced by LPS (Lee et al., 1999;
Tajima et al., 2003). Our results support and extend the latter
conclusion. The synergistic effects of caffeine on LPS-induced
maturation are sensitive to cyclosporine A and deltamethrin,
implying the involvement of calcineurin (Barford, 1996; Enan
and Matsumara, 1992) in RyR1-induced maturation of DCs. In
addition, our data demonstrate that the low-amplitude calcium
signal mediated by RyR synergizes with LPS in inducing DC
maturation, whereas the large Ca2+ transient induced by ATP
does not promote the expression of genes associated with DC
maturation. On the basis of these data, one may postulate that
amplitude modulation of the Ca2+ signal is a mechanism
contributing to the maturation of DCs. A similar control by
amplitude modulation of the Ca2+ signal has been proposed to
play an important role in B-lymphocyte signaling (Dolmetsch
et al., 1997). High LPS concentrations may engage a sufficient
number of Toll-like receptors, and thereby the cooperation of
additional signaling pathways is not required to fully activate
DCs. The model emerging from our data indicates that NF-kB
and calcineurin signaling pathways may ultimately converge to
regulate the transcription of a set of genes involved in DC
maturation. A similar complex regulatory mechanism has been
reported for the transcription of the IL4 gene in T cells, which
is under the control of several transcription factors, including
NF-kB, NF-AT and NF-IL6 (Li-Weber et al., 2004).
Finally, on a lighter note, based on these findings one may
envisage that by drinking caffeine-containing beverages
containing up to 85 mg/150 ml caffeine (Barone and Roberts,
1996) (i.e. 3 mM), iDCs residing in the gut may be exposed to
concentrations of caffeine sufficient to activate them,
especially in the presence of low levels of bacterial derivatives
(Iwasaki and Kelsall, 1999), thereby enhancing their antigen-
presenting capacity. Thus, relatively small amounts of antigens
may be sufficient to induce effective T-cell responses and
protection against enteric infections.
Materials and Methods
DC generation and stimulation
iDCs were generated from human peripheral blood mononuclear cells (PBMC) as
previously described (Schnurr et al., 2004). Briefly, monocytes were purified by
positive sorting using anti-CD14-conjugated magnetic microbeads (Miltenyi
Biotech, Bergisch Gladbach, Germany). The recovered cells (95-98% purity) were
cultured for 5 days at 3105/ml in differentiation medium containing: RPMI, 10%
FCS glutamine, non-essential amino acids and antibiotics (all from Invitrogen,
Basel, Switzerland), supplemented with 50 ng/ml GM-CSF (Laboratory Pablo
Cassarà, Buenos Aires, Argentina) and 1000 U/ml IL4 (a gift from A. Lanzavecchia,
Institute for Research in Biomedicine, Bellinzona, Switzerland). Maturation was
induced by an 18-hour culture, unless otherwise stated, in the presence of the Toll-
like receptor-4 agonist LPS (from Salmonella abortus equi; Sigma Chemicals, St
Louis, MO) at the doses indicated in the different experiments. The phenotype of
the cells was evaluated prior to and after maturation by flow cytometry. Briefly, cells
were washed and resuspended in phosphate-buffered saline (PBS). They were then
incubated for 30 minutes at 4°C in the presence of 1:20 dilutions of fluorochrome-
labeled commercial monoclonal antibodies recognizing the following surface
markers: CD1a, CD14, CD40, CD80, CD86, CD83, CD54, HLA-ABC, HLA-DR,
CD3, CD19 and CD56, or isotype-matched controls (BD Pharmingen, Basel,
Switzerland). After two washes, specific fluorescence was evaluated by flow
cytometry, by using a FACSCalibur instrument equipped with Cell Quest software
(Becton Dickinson, San Josè, CA). Plasmacytoid DCs were magnetically isolated
from peripheral blood using BDCA-2 DC isolation kits (Miltenyi Biotec, Bergisch
Gladbach, Germany) according to the manufacturer’s instructions. The number and
viability of DCs was determined by trypan blue exclusion and purity was assessed
by flow cytometry. For functional experiments, in vitro-derived iDCs were cultured
Fig. 6. Cartoon depicting signaling pathways involved
in DC maturation. In the presence of sub-optimal Toll-
like receptor ligand, the signal(s) generated from cells
dying in the vicinity of iDCs bind to receptors that are
coupled to the RyR1, activating calcium release. This
intracellular pathway leading to DC maturation through
RyR1 activation is dependent upon the activity of
calcineurin as it could be blocked by cyclosporine A
and deltamethrin. PM, plasma membrane.
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in the presence of the indicated concentration of LPS ± 10 mM caffeine ± 20 M
dantrolene or a standard, optimal concentration of LPS (1 g/ml) as control for the
indicated time period. In some experiments, iDCs were stimulated with 100 M
ATP as indicated or with 100 mM KCl plus 1 ng/ml LPS for 30 minutes, followed
by removal of KCl and addition of differentiation medium containing 1 ng/ml LPS
for 4 hours. When the latter protocol was applied, NaCl was substituted for KCl in
order to maintain osmolarity of the medium. For experiments in which iDCs were
incubated with the supernatant of necrotic cells, experiments were performed
essentially as described by Sauter et al. (Sauter et al., 2002); briefly, 6106 HEK293
cells were rinsed twice with PBS, resuspended in 3 ml PBS and subjected to five
cycles of freeze-thawing. Viability was assessed by trypan blue exclusion and was
>95%. Cells were centrifuged, the resulting supernatant was filtered through a 0.2
m Millipore filter and one half was added to iDC cultures (0.8106 cells) in 1 ml
differentiation medium plus a final concentration of 1 ng/ml LPS; the other half was
added to iDCs that had been pretreated with 20 M dantrolene for 30 minutes and
then processed as described above. Cells were incubated for 4 hours at 37°C. For
experiments in which iDCs were incubated with the dialysed supernatant of necrotic
cells, experiments were performed as described above, except that the supernatants
were dialysed overnight against 1PBS, filtered and then added to iDCs.
Ryanodine receptor isoform expression
Total RNA was isolated from leukocyte populations and reverse transcribed into
cDNA as previously described (Girard et al., 2001). The expression of genes
encoding ryanodine receptor isoforms was investigated by PCR analysis using
previously reported specific primers and conditions (Hosoi et al., 2001).
Immunofluorescence analysis and single-cell intracellular Ca2+
measurements
Immunofluorescence analysis was performed on paraformaldehyde-fixed DCs using
allophycocyanine-conjugated anti-CD1a (BD Pharmingen), or on acetone:methanol
(1:1)-fixed iDCs, using a goat anti-RyR raised against the NH2-terminus and
recognizing the three RyR isoforms (Santa Cruz Biotech), followed by Alexa Fluor-
555-conjugated donkey anti-goat antibodies (Molecular Probes) or rabbit anti-NF-
kB (sc-109; Santa Cruz Biotech), followed by Alexa Fluor-488-conjugated chicken
anti-rabbit antibodies (Molecular Probes), as previously described (Ducreux et al.,
2004). Fluorescence was visualized using a 100 Plan Neofluar oil immersion
objective (NA 1.3) mounted on a Zeiss Axiovert 100 confocal microscope.
Single-cell intracellular calcium measurements were performed on fura-2-loaded
iDCs attached to poly-L-lysine-treated glass coverslips mounted onto a 37°C
thermostated chamber that was continuously perfused with Krebs-Ringer medium
containing 1 mM CaCl2. Individual cells were stimulated with the indicated agonist
in Krebs-Ringer (plus 1 mM CaCl2) by way of a 12-way 100 mm diameter quartz
micromanifold computer-controlled microperfuser (ALA Scientific, Westbury, NY),
as previously described (Ducreux et al., 2004). Online (340 nm, 380 nm and ratio)
measurements were recorded using a fluorescent Axiovert S100 TV inverted
microscope (Carl Zeiss, Jena, Germany) equipped with a 40 oil immersion Plan
Neofluar objective (0.17 NA), filters (BP 340/380, FT 425, BP 500/530) and attached
to a Hamamatsu multiformat CCD camera. The cells were analyzed using an Openlab
imaging system and the average pixel value for each cell was measured at excitation
wavelengths of 340 and 380 nm, as previously described (Ducreux et al., 2004).
Quantitative gene expression analysis
Eighteen hours after stimulation, total RNA was extracted from DCs (Qiagen, Basel,
Switzerland) and treated with Deoxyribonuclease I (DNase I) (Invitrogen, Carlsbad,
CA) to eliminate contaminant genomic DNA. After reverse transcription using the
Moloney MurineLeukemia Virus Reverse Transcriptase (M-MLV RT) (Invitrogen),
cDNA was amplified by quantitative real-time PCR in the ABI PrismTM 7700 using
the TaqMan® technology. Commercially available exon-intron junction-designed
primers for GAPDH, CD83, IFN, IL12B and IL23A (Applied Biosystems, Forster
City, CA) were used. Gene expression was normalized using self-GAPDH as
reference.
Allostimulatory properties of DCs
Allostimulatory capacity of DCs treated with different concentrations of LPS alone
or with 100 M ATP, 10 mM caffeine plus or minus 20 M dantrolene, was assayed
by standard mixed lymphocyte reaction (MLR) tests by culturing cells in the
presence of allogenic PBMC in RPMI medium supplemented with 5% pooled
human serum at a 10:1 ratio (Mohty et al., 2002). Lymphocyte proliferation was
evaluated by [3H]-thymidine incorporation.
Activation of intracellular signaling pathways
NF-kB translocation was monitored by indirect immunofluorescence on DCs treated
with LPS and/or caffeine (10 mM) as indicated, for 5 or 60 minutes at 37°C. Cells
were fixed with acetone:methanol and processed as described above for RyR
immunofluorescence, using rabbit anti-NF-kB [anti-p65 (RelA) polyclonal
antibodies; Santa Cruz Biotech], followed by Alexa Fluor-488-conjugated chicken
anti-rabbit antibodies (Molecular Probes).
Involvement of the calcium/calmodulin-dependent calcineurin signaling pathway
was determined by studying the sensitivity of CD83 surface expression to
cyclosporine A or deltamethrin. Briefly, iDCs were pretreated with carrier,
cyclosporine A (2 M) (Sigma Chemicals) or deltamethrin (10 M) (Fluka
Chemicals, Buchs, Switzerland) for 30 minutes, followed by incubation for 4 hours
with 1 g/ml LPS or sub-optimal concentrations of LPS in the presence or absence
of 10 mM caffeine. Cells were harvested and surface expression of CD83 was
investigated by flow cytometry using FITC-labeled anti-CD83 monoclonal
antibodies (BD Pharmingen).
Statistical analysis and software programs
Statistical analysis was performed using the Student’s t-test for unpaired samples;
means were considered statistically significant when the P value was <0.05. The
Origin computer program (Microcal Software, Northampton, MA) was used to
generate graphs and for statistical analysis; figures were assembled using Adobe
Photoshop.
This work was supported by the Departments of Anesthesia and
Surgery of the Basel University Hospital, by grants 3200-067820.02,
3200B0-114597, 3200B0-04060/1 of the SNF and grants from the
Swiss Muscle Foundation and Association Française Contre les
Myopathies. We also wish to thank Chantal Feder-Mengus for her
support in performing real-time PCR.
References
Banchereau, J. and Steinman, R. M. (1998). Dendritic cells and the control of immunity.
Nature 392, 245-252.
Barford, D. (1996). Molecular mechanisms of the protein serine/threonine phosphatases.
Trends Biochem. Sci. 21, 407-412.
Barone, J. J. and Roberts, H. R. (1996). Caffeine consumption. Food Chem. Toxicol.
34, 119-129.
Berridge, M., Bootman, M. D. and Roderick, H. L. (2003). Calcium signalling:
dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4, 517-529.
Bers, D. M. (2004). Macromolecular complexes regulating cardiac ryanodine receptor
function. J. Mol. Cell. Cardiol. 37, 417-429.
Ciesek, S., Ringe, B. P., Strassburg, C. P., Klempnauer, J., Manns, M. P., Wedemeyer,
H. and Becker, T. (2005). Effects of cyclosporine on human dendritic cell subsets.
Transplant. Proc. 27, 20-24.
Czerniecki, B. J., Carter, C., Rivoltini, L., Koski, G. K. H., Kim, I., Weng, D. E.,
Roros, J. G., Hijazi, Y. M., Xu, S., Rosenberg, S. A. et al. (1997). Calcium
ionophore-treated peripheral blood monocytes and dendritic cells rapidly display
characteristics of activated dendritic cells. J. Immunol. 159, 3823-3837.
Dolmetsch, R. E., Lewis, R. S., Goodnow, C. C. and Healey, J. I. (1997). Differential
activation of transcription factors induced by Ca2+ response amplitude and duration.
Nature 386, 856-858.
Ducreux, S., Zorzato, F., Müller, C. R., Sewry, C., Muntoni, F., Quinlivan, R.,
Restagno, G., Girard, T. and Treves, S. (2004). Effect of ryanodine receptor
mutations on interleukin-6 release and intracellular calcium homeostasis in human
myotubes from malignant hyperthermia-susceptible individuals and patients affected
by central core disease. J. Biol. Chem. 2279, 43838-43846.
Enan, E. and Matsumara, F. (1992). Specific inhibition of calcineurin by type II
synthetic pyrethroid insecticides. Biochem. Pharmacol. 15, 1777-1784.
Faries, M. B., Bedrosian, I., Xu, S., Koski, G., Roros, J. G., Moise, M. A., Nguyen,
H. Q., Friederike, H., Engels, H. C., Cohen, P. A. et al. (2001). Calcium signaling
inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce
Th2 cell development. Blood 98, 2489-2497.
Franzini-Armstrong, C. and Protasi, F. (1997). Ryanodine receptors of striated muscles:
a complex channel capable of multiple interactions. Physiol. Rev. 77, 699-729.
Gardella, S., Andrei, C., Lotti, L. V., Poggi, A., Torrisi, M. R., Zocchi, M. R. and
Rubarteli, A. (2001). CD8(+) T lymphocytes induce polarized exocytosis of secretory
lysosomes by dendritic cells with release of interleukin-1beta and cathepsin D. Blood
98, 2152-2159.
Ghosh, S., May, M. J. and Kopp, E. B. (1998). NF-kB and Rel proteins: evolutionary
conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
Girard, T., Cavagna, D., Padovan, E., Spagnoli, G., Urwyler, A., Zorzato, F. and
Treves, S. (2001). B-lymphocytes from malignant hyperthermia-susceptible patients
have an increased sensitivity to skeletal muscle ryanodine receptor activators. J. Biol.
Chem. 276, 48077-48082.
Goth, S. R., Chu, R. A., Gregg, J. P., Cjerednichenko, G. and Pessah, I. N. (2006).
Uncoupling of ATP-mediated calcium signaling and dysregulated interleukin-6
secretion in dendritic cells by nanomolar thimerosal. Environ. Health Perspect. 114,
1083-1091.
Grohmann, U., Belladonna, M. L., Bianchi, R., Orabona, C., Ayroldi, E., Fioretti, M.
C. and Puccetti, P. (1998). IL-12 acts directly on DC to promote nuclear translocation
of NF-kB and primes DC for IL-12 production. Immunity 9, 315-323.
Iwasaki, A. and Kelsall, B. L. (1999). Mucosal immunity and inflammation. I. Mucosal
dendritic cells: their specialized role in initiating T cell responses. Am. J. Physiol. 276,
G1074-G1078.
Hosoi, E., Nishizaki, C., Gallagher, K. L., Wyre, H. W., Matsuo, Y. and Sei, Y. (2001).
Expression of the ryanodine receptor isoforms in immune cells. J. Immunol. 167, 4887-
4894.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
Koski, G. K., Schwartz, G. N., Weng, D. E., Czerniecki, B. J., Carter, C., Gress, R.
E. and Cohen, P. A. (1999). Calcium mobilization in human myeloid cells results in
acquisition of individual dendritic cell-like characteristics through discrete signaling
pathways. J. Immunol. 163, 82-92.
Lachmann, M., Berchtold, S., Hauber, J. and Steinkasserer, A. (2002). CD83 on
dendritic cells: more than just a marker for maturation. Trends Immunol. 23, 273-275.
Lee, J., Ganster, R. W., Geller, D. A., Burckart, G. J., Thomson, A. W. and Lu, L.
(1999). Cyclosporine A inhibits the expression of co-stimulatory molecules on in vitro-
generated dendritic cells. Transplantation 68, 1255-1263.
Li-Weber, M., Giasi, M., Baumann, S., Palfi, K. and Krammer, P. H. (2004). NF-kB
synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells. Eur. J.
Immunol. 34, 1111-1118.
McPherson, P. S. and Campbell, K. P. (1993). Characterization of the major brain form
of the ryanodine receptor/Ca2+ release channel. J. Biol. Chem. 268, 13765-13768.
Mohty, M., Isnardon, D., Charbonnier, A., Lafag-Pochitaloff, M., Merlin, M., Sainty,
D., Olive, D. and Gaugler, B. (2002). Generation of potent T(h)1 responses from
patients with lymphoid malignancies after differentiation of B lymphocytes into
dendritic-like cell. Int. Immunol. 14, 741-750.
O’Connell, P. J., Klyachko, V. A. and Ahern, G. P. (2002). Identification of functional
type 1 ryanodine receptors in mouse dendritic cells. FEBS Lett. 512, 67-70.
Otsu, K., Willard, H. F., Khanna, V. J., Zorzato, F., Green, N. M. and MacLennan,
D. H. (1990). Molecular cloning of cDNA encoding the Ca2+ release channel
(ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J. Biol. Chem.
265, 13472-13483.
Phillips, M., Fujii, J., Khanna, V. K., DeLeon, S., Yokobata, K., de Jong, P. J. and
MacLennan, D. H. (1996). The structural organization of the human skeletal muscle
ryanodine receptor (RYR1) gene. Genomics 34, 24-41.
Ralevic, R. and Burnstock, G. (1998). Receptors for purines and pyrimidines.
Pharmacol. Rev. 50, 413-455.
Sallusto, F. and Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by
cultured human dendritic cells is maintained by granulocyte/macrophage colony-
stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
J. Exp. Med. 179, 1109-1118.
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin,
S. and Lanzavecchia, A. (1998). Rapid and coordinated switch in chemokine receptor
expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760-2769.
Samso, M., Wagenknecht, T. and Allen, P. D. (2005). Internal structure and visualization
of transmembrane domains of the RyR1 calcium release channel by cryo-EM. Nat.
Stuct. Mol. Biol. 12, 539-544.
Sauter, B. B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S. and Bhardwaj,
N. (2000). Consequences of cell death: exposure to necrotic tumor cells but not primary
tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic
cells. J. Exp. Med. 191, 423-433.
Schnurr, M., Shin, A., Hartmann, G., Rothenfusser, S., Soellner, J., Davis, I. D.,
Cebon, J. and Maraskovsky, E. (2004). Role of adenosine receptors in regulating
chemotaxis and cytokine production of plasmacytoid dendritic cells. Blood 103, 1391-
1397.
Sei, Y., Gallagher, K. L. and Basile, A. S. (1999). Skeletal muscle type ryanodine
receptor is involved in calcium signaling in human B lymphocytes. J. Biol. Chem. 274,
5995-6002.
Serysheva, I. I., Hamilton, S. L., Chiu, W. and Ludtke, S. J. (2005). Structure of Ca2+
release channel at 14 A resolution. J. Mol. Biol. 21, 427-431.
Sorrentino, V., Giannini, G., Malzac, P. and Mattei, M. G. (1993). Localization of a
novel ryanodine receptor gene (RYR3) to human chromosome 15q14-q15 by in situ
hybridization. Genomics 18, 163-165.
Stolk, M., Leon-Ponte, M., Merrill, M., Ahern, G. P. and O’Connell, P. J. (2006).
IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. J. Leuk.
Biol. 80, 651-658.
Sutko, J. L. and Airey, J. A. (1996). Ryanodine receptor Ca2+ release channels: does
diversity in form equal diversity in function? Physiol. Rev. 76, 1027-1071.
Tajima, K., Amakawa, R., Ito, T., Miyaji, M. and Takebayashi, M. (2003).
Immunomodulatory effects of cyclosporine A on peripheral blood dendritic cell
subsets. Immunology 108, 321-328.
Takeshima, H., Nishimura, S., Matsumoto, T., Ishida, H., Kangawa, K., Minamino,
N., Matsuo, H., Ueda, M., Hanaoka, M., Hirose, T. et al. (1989). Primary structure
and expression from complementary DNA of skeletal muscle ryanodine receptor.
Nature 339, 439-445.
Tarroni, P., Rossi, D., Conti, A. and Sorrentino, V. (1997). Expression of the ryanodine
receptor type 3 calcium release channel during development and differentiation of
mammalian skeletal muscle cells. J. Biol. Chem. 272, 19808-19813.
Treves, S., Anderson, A. A., Ducreux, S., Divet, A., Bleuven, C., Grasso, C., Paesante,
S. and Zorzato, F. (2005). Ryanodine receptor 1 mutations, dysregulation of calcium
homeostasis and neuromuscular disorders. Neuromuscul. Disord. 15, 577-587.
Zhao, F., Li, P., Chen, S. R., Louis, C. F. and Fruen, B. R. (2001). Dantrolene inhibition
of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform
selectivity. J. Biol. Chem. 276, 13810-13816.
Zhou, L. J. and Tedder, T. F. (1996). CD14+ blood monocytes can differentiate into
functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 93, 2588-
2592.
Zorzato, F., Fujii, J., Otsu, K., Phillips, M., Green, N. M., Lai, F. A., Meissner, G.
and MacLennan, D. H. (1990). Molecular cloning of cDNA encoding human and
rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle
sarcoplasmic reticulum. J. Biol. Chem. 265, 2244-2256.
Zucchi, R. and Ronca-Testoni, S. (1997). The sarcoplasmic reticulum Ca2+
channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease
states. Pharmacol. Rev. 49, 1-51.
Journal of Cell Science 120 (13)2240
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
